Viewing Study NCT02069834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-03-04 @ 9:54 PM
Study NCT ID: NCT02069834
Status: WITHDRAWN
Last Update Posted: 2015-08-28
First Post: 2014-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Dolutegravir + Rilpivirine Switch Study (DORISS)
Sponsor: Nantes University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
None HAART-treated View
None Virologically Controlled View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dolutegravir View
None Rilpivirine View
None PI- and NRTI- sparing ART regimen View
None switch study View